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Abstract Minimal change disease (MCD), the most common
idiopathic nephrotic syndrome in children, is characterized by
proteinuria and loss of glomerular visceral epithelial cell
(podocyte) ultrastructure. Lipopolysaccharide (LPS) and puromycin aminonucleoside (PAN) are used to study podocyte
injury in models of MCD in vivo and in vitro. We hypothesized that LPS and PAN influence components of the innate
immune system in podocytes such as the Toll-Like Receptor
(TLRs), TLR adapter molecules, and associated cytokines.
Our results show that cultured human podocytes constitutively
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express TLRs 1–6 and TLR-10, but not TLRs 7–9. LPS
(25 μg/ml) or PAN (60 μg/ml) caused comparable derangement of the actin cytoskeleton in podocytes. Quantitative RTPCR analysis show that LPS differentially up-regulated the
expression of genes for TLRs (1>4≥2>3>6>5), the adapter
molecule, MyD88, and transcription factor NF-κB within one
hour. LPS also caused increased levels of IL-6, IL-8 and
MCP1 without exerting any effect on TNF-α, IFN-α or
TGF-β1 at 24 h. Immunofluorescence intensity analysis of
confocal microscopy images showed that LPS induced a
significant increase in nuclear translocation of NF-κB by
6 h. In contrast, PAN-induced only small changes in the
expression of TLRs 2–6 that included a persistent increase
in TLRs 2 and 5, a transient increase in TLR-4, and a gradual
increase in TLRs 3 and 6 between 1 and 6 h. Correspondingly,
it did not alter pro-inflammatory cytokine levels in podocytes.
However, PAN induced a low but significant increase in NFκB nuclear translocation within one hour that remained unchanged up to 6 h. In summary, these novel findings
show that LPS, a known TLR-4 ligand, induced the gene
expression of multiple TLRs with maximum effect on the
expression of TLR-1 suggesting a loss of receptor selectivity and induction of receptor interactions in podocytes.
A comparable derangement of the podocyte cytoskeleton
and significant increase in the nuclear translocation of NFκB by PAN suggest that disparate but complementary
mechanisms may contribute to the development of podocytopathy in MCD.
Keywords Innate immunity . Toll-like receptors .
Cytokines . Lipopolysaccharide . Puromycin
Aminonucleoside . Minimal Change Disease . Glomerular
filtration barrier . Podocytes
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Introduction
Minimal change disease (MCD), characterized by proteinuria without evidence of renal damage at the level of light
microscopy, is the most common diagnosis for idiopathic
nephrotic syndrome in children (Srivastava et al. 1999).
Immunological factors are implicated in pathogenesis of
MCD because effective control of proteinuria is achieved
with immunosuppressive agents, and relapse occurs following
viral or bacterial infection (Neuhaus et al. 1994; MacDonald et
al. 1986). Several non-immunoglobulin mediators including
cytokines, T cell products and vasoactive agents are associated
with MCD. However, renal biopsies from MCD patients do
not show inflammatory cells, complement proteins or immune
deposits (Mathieson 2007). Therefore, the etiology of MCD
requires further investigation.
A significant role for the innate immune system in the
onset and progression of MCD is implied by the available
evidence but the nature of the participating molecules and
signaling pathways remains unclear. The innate immune system relies on an extensive network of molecules and signaling
mechanisms, many of which involve the pattern-recognizing
Toll-like receptors (TLRs) 1–10 (Takeda and Akira 2004).
Figure 1 summarizes TLR-mediated signaling through either
of the two major adapter molecules, myeloid differentiation
factor (MyD88-dependent) or Toll-Interleukin 1 Receptor
(TIR) domain-containing adapter-inducing interferon-β
(TRIF, MyD88-independent). MyD88-dependent signaling
leads to translocation of NF-κB and transcription of the genes
for proinflammatory cytokines, such as TNF-α, IL-1β, IL-6
and IL-10. The TRIF-dependent pathway causes transcription
of Type-I interferons (IFN), such as IFN-α and IFN-β
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(Yamamoto et al. 2003; Carmody and Chen 2007).
Signaling pathways of the innate immune system have largely
been studied in leukocytes, but recent studies point to the
importance of understanding TLR signaling in epithelial cells
exposed to injury or infection (Gribar et al. 2008).
Podocytes (visceral epithelial cells) with the basement
membrane and capillary endothelium constitute the glomerular filtration barrier that regulates the passage of plasma
protein into urine. The location and function of podocytes
expose them to metabolic toxins, bacterial and viral products. Electron microscopy of renal biopsies from MCD
patients reveals extensive foot process effacement and condensation of the actin cytoskeleton in podocytes. These ultrastructural changes are sufficient to explain the increased
glomerular permeability to macromolecules and the amount
of urinary protein observed in MCD (Lane and Kaskel 2009).
Puromycin aminonucleoside (PAN) and lipopolysaccharide (LPS) are unrelated molecules that cause comparable
podocyte injury in vitro and in vivo. LPS, a complex of lipid
A (endotoxin) and oligosaccharide from gram negative bacterial cell wall, is a known ligand of TLR-4 that activates
leukocytes at very low concentration quantities (nanograms/
mL); however, microgram/mL quantities of LPS are required to induce injury to podocytes in current models of
MCD. Previous work has focused on TLR-4 as the only
receptor of LPS (Reiser et al. 2004; Brown et al. 2007;
Banas et al. 2008). PAN, an aminonucleoside, is not known
to activate TLRs. A likely effect of the amount of LPS used
in models of MCD on multiple TLR subtypes and, on its
specificity for TLR-4 has not been addressed. Although LPS
and PAN induce cellular injury through distinct mechanisms, they result in comparable changes in cell morphology
and cytoskeleton suggesting a convergence of pathways.
We, for the first time, carried out a head to head comparison
of the effect of LPS and PAN on the gene expression of TLR
subtypes, signaling elements and on the production of proinflammatory cytokines in cultured podocytes.

Materials and methods
Cell culture

Fig. 1 Schematic representation of major TLR signaling pathways.
The toll-like receptor (TLR) signaling pathways converge through two
major signaling molecules, MyD88 or TRIF. The MyD88-dependent
pathway activates NF-κB and transcription of inflammatory cytokines.
The TRIF pathway leads to transcription of type I Interferons.
[MyD88: myeloid differentiation primary-response protein 88, IFN:
Interferon, IRF-3: IFN-regulatory factor-3, NF-κB: Nuclear factorκB, LRR: leucine rich repeats, TIR: Toll/interleukin-1 receptor, TRIF:
TIR-domain-containing adaptor protein inducing IFN-β]

Conditionally immortalized transgenic human podocytes
enabled via a thermosensitive variant of SV-40 were provided by Dr. Moin Saleem. Briefly, podocytes were cultured
in RPMI-1640 with insulin (10 μg/ml), transferrin (5.5 μg/
ml), selenium (5 ng/ml Na selenite), heat-inactivated fetal
bovine serum (10 %v/v), 100 U/ml penicillin and 0.1 mg/ml
streptomycin (Invitrogen, Carlsbad, CA) at 33 °C under a
humidified atmosphere of 95 % air and 5 % CO2 with
change of the medium every 2 days. Podocytes at 50–
60 % confluence were thermo-switched from 33 °C to
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37 °C for differentiation under non-permissive conditions
for 14 days. Differentiated podocytes were used in all
experiments (Saleem et al. 2002).
Two cell types were used as reference controls for comparing PCR results. Human monocytic cells (THP-1) and
human foreskin fibroblasts (HFF) were purchased from
ATCC (Manassas, VA) and grown in RPMI or DMEM,
respectively, with 2 mM L-gluatamine, 250 μg/ml amphotericin, 100U/ml penicillin, 0.1 mg/ml streptomycin and
10 % fetal bovine serum at 37 °C in humidified atmosphere
of 95 % air and 5 % CO2. At 90 % confluence, THP-1 and
HFF cells at passages 10–12 were plated at a density of ~105
cells/well in 12-well plates with serum-free RPMI overnight
prior to experimental treatment(s).
Treatment of cultured podocytes using Puromycin
Aminonucleoside (PAN) and Lipopolysaccharide (LPS)
Cells were maintained in serum-free RPMI-1644 medium
for 24 h prior to treatment with either PAN (Sigma Chemical
Company, St. Louis, MO) or purified E. Coli LPS from E.
Coli O111:B4 strain (InvivoGen, San Diego, CA). During
preliminary work, podocytes were treated with several concentrations of PAN (0–90 μg/ml) or LPS (0–50 μg/ml) for
up to 24 h to assess changes in cell morphology (0.1 %
crystal violet stain) and actin cytoskeleton (phalloidin conjugated Alexa Fluor 568, Invitrogen, Carlsbad, CA) to determine optimum concentrations for subsequent studies.
Further experiments were conducted in triplicates using
60 μg/ml PAN or 25 μg/ml LPS to study TLR mRNA
expression by quantitative real time polymerase chain reaction (qRT-PCR) at 1 h (early) and 6 h (late), and secreted
cytokines into the medium at 6 h (early) and 24 h (late). The
concentrations of LPS and PAN used in these studies are
within the range used in other acute in vitro studies.
Currently established models of podocyte injury use comparable or higher doses of PAN and LPS (Reiser et al. 2004;
Banas et al. 2008; Suzuki et al. 2001; Marshall et al. 2006;
Gloy et al. 2000; Coers et al. 1994).
Phalloidin staining for F-actin and crystal violet staining
for cell morphology in podocyte
Fluorescence or bright field microscopy was used to evaluate the changes in cell structure and the actin cytoskeleton
caused by LPS or PAN at the concentrations indicated. Prior
to phalloidin staining for F-actin, cells were washed with
phosphate buffered saline (PBS) and fixed with 4 % paraformaldehyde. Phalloidin conjugated with Alexa Fluor 568
dye (Invitrogen A12380) was used to assess the actin cytoskeleton in podocytes. Cell morphology was assessed by
first fixing PBS-washed cells in 2 % glutaraldehyde for
10 min followed by staining with 0.1 % crystal violet for
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20 min. Images were obtained from 10–20 random fields in
a masked manner using Olympus BX60 fluorescence microscope (Hamburg, Germany).
RNA extraction and qualitative reverse transcription
polymerase chain reaction (RT-PCR)
RT-PCR was used to evaluate the expression of TLRs 1–10
and their principal signal elements MD-1 (lymphocyte antigen 86, LY86) and MD-2 (lymphocyte antigen 96, LY96),
the cysteine-rich molecules that bind the leucine-rich region
of TLRs and mediate interaction with LPS. The expression
of TLRs in HFF and THP-1 cells has been previously
described and these cells were used as reference quality
controls (Yew et al. 2010).
Total RNA was isolated using RNeasy Mini Kit (Qiagen,
Valencia, CA) following the manufacturer’s instructions.
The concentration and quality of RNA was determined
spectrophotometrically at 260/280 nm using Nanodrop
spectrophotometer (Pharmacia Biotech, Piscataway, NJ).
Total RNA was reverse-transcribed to generate cDNA using
Qiagen Sensiscript Reverse Transcriptase for RT-PCR using
standard method and cDNA was stored at−20 °C until use.
The cDNA generated from reverse transcription of RNA
was amplified by PCR for 40 cycles (initial denaturation at
95 °C for 10 min, followed by 40 cycles at 94 °C (30 sec),
60 °C (30 sec), 72 °C (30 sec) and the final extension at 72 °C
for 10 min) with specific primer sets (Table 1). The forward
and reverse primers used are shown in Table 1. PCR products
were separated by electrophoresis in 2 % agarose gel
for RT-PCR, exposed to ethidium bromide and fluorescent
images were obtained. RT-PCR data were analyzed qualitatively and scored using an arbitrary numeric scale (0–4+) in a
masked manner.
Quantitative real time polymerase chain reaction (qRT-PCR)
We used qRT-PCR to evaluate the effect of LPS or PAN on
TLR expression. Total RNA was extracted and purified as
described. PCR amplifications were performed using a
BioRad iCycler® (Hercules, CA) sequence detection system. A 50 μl reaction mixture including 10X Gold Buffer,
25 mm MgCl2, 2.5 mM dNTPs, 10X SYBR Green, Taq
Gold polymerase, dH2O, DNA template and 10 μM of each
primer was used for PCR. Amplification was performed by
initial polymerase activation (10 min) at 95 °C, and 40 cycles
of denaturation at 95 °C (15 sec), annealing at 60 °C
(20 sec) and elongation (30 sec) at 72 °C. PCR efficiency
was examined by serially diluting the template cDNA and
PCR specificity by obtaining melting curve data. Proper controls were included in each assay. Gene-specific mRNA expression was calculated with reference to the standard cDNA
dilution curve and expressed as mol/μL. The relative gene-
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Table 1 Forward and reverse
primers used in reverse transcription polymerase chain reaction (RT-PCR) and quantitative
real time polymerase chain reaction (qRT-PCR) for different
components of TLR signaling
pathway in podocyte

T. Srivastava et al.

Forward primer

Reverse primer

TLR1
TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TLR8
TLR9
TLR10
MD-1
MD-2
TRIF
IRF-3

TCAAGCACTTGGACCTGTCA
GGGTTGAAGCACTGGACAAT
CCGCCAACTTCACAAGGTAT
CGGAGGCCATTATGCTATGT
ATCGTTTCTGCAACCTCACC
AGGGCTGGCCTGATTCTTAT
TGCTGTGTGGTTTGTCTGGT
CATCATCGACAACCTCATGC
AATTCCCATCTCTCCCTGCT
ACTTTGCCCACCACAATCTC
GGGCCTGTCAATAATCCTGA
CCGAGGATCTGATGACGATT
ACGCCACTCCAACTTTCTGT
GATGCACAGCAGGAGGATTT

GCAATTGGCAGCACACTAGA
CTGCCCTTGCAGATACCATT
AGCTCATTGTGCTGGAGGTT
TCCCTTCCTCCTTTTCCCTA
AAGGGGAAGGATGAAGCAGT
TGGTGACGATCAGCAGAGTT
GATCACACTTTGGCCCTTGT
TAGCCTCTGCAAAGCCAAGT
TCCTTCACCCCTTCCTCTTT
CTTGGGCCATTCCAAGTATG
TTTGCTACAGGCCACAGTCA
TGGGCTCCCAGAAATAGCTT
TCAGGTGAGCTGAACAAGGA
TCTGCTAAACGCAACCCTTC

133
134
130
141
106
114
109
121
135
146
137
142
136
149

MyD88
NF-κB p65

TGCAGAGCAAGGAATGTGAC
TGGAGTCTGGGAAGGATTTG

AGGATGCTGGGGAACTCTTT
CGAAGCTGGACAAACACAGA

121
129

specific mRNA expression (RE) was normalized against
mRNA expression for β-actin as follows: RE for genespecific mRNA0gene-specific mRNA [mol/μL] ÷ β-actin
mRNA [mol/μL].
Nuclear translocation of NF-κB
NF-κB nuclear translocation in podocytes were determined by
indirect immunofluorescence followed by specific measurement of NF-κB immunorectivity overlapping with DAPIlabeled nuclei relative to NF-κB immunoreactivity in nonnuclear (cytosolic) compartments. Immunofluorescence was
performed using primary rabbit anti-NF-κB antibody at
1:1,000 (#04-235 from Millipore Corporation, Billerica,
MA) and secondary goat anti-rabbit IgG at 1:2,500
(Invitrogen). Images for analysis were acquired using a Zeiss
LSM-510 laser scanning confocal microscope at 63X magnification. Z-stack images were obtained and resulting maximum intensity projection images were used for analysis.

PCR size (bp)

for 1 h, washed and mixed with streptavidin-conjugated
R-phycoerythrin to form a four-member solid phase sandwich. The Luminex 200 TM dual laser identifies the bead by its
spectral property and the protein concentration is determined
by extrapolating the amount of R-phycoerythrin fluorescence
to the standard curve. We measured IL-6, IL-8, MCP-1, MIP1α, IP-10, TNF-α, IFN-α, and TGF-β1 in duplicates in the
medium. IFN-β was measured by an ELISA kit (R&D
Systems, Piscataway, NJ) following the manufacturer’s
instructions. Measured cytokine was corrected for DNA content of lysate, and was expressed as pg cytokine/μg DNA.
Statistical analysis
Data were analyzed using the SPSS 18.0 statistical software (SPSS Inc., Chicago, IL) for three group comparison. A p<0.05 value was considered significant.

Results
Multiplex bead-based immunoassay for secreted cytokines
Secreted cytokines in the medium were assayed to determine the effect of PAN or LPS on podocytes at 6 h and 24 h
using a Luminex 200TM platform (Invitrogen). First, the
supernatants were concentrated 20-fold by centrifugationbased filtration using Amicon Centricon-10 (Millipore
Corporation, Billerica, MA) with a molecular weight cutoff of 10 kD. The medium was not concentrated for IL-6
assay. Concentrated media (50 μl) or standards of known
protein concentrations were added to antibody-conjugated
beads and incubated for 2 h. Beads were washed and incubated with protein-specific biotinylated detector antibodies

Toll-Like Receptors (TLRs) are expressed in human
podocytes
Table 2 shows a comparison of the gene expression for
TLRs, MD-1 and MD-2 in podocytes cultured with or
without FBS. Podocytes showed constitutive expression of
the genes for TLR-1, 2, 3, 4, 5, 6 and 10, but not for TLR-7,
8 or 9. Most TLRs are transmembrane cell surface receptors,
but TLR-7, 8 and 9 are exclusively endosomal receptors,
and TLR-3 has been localized at both sub-cellular sites.
Thus, cell surface rather than endosomal TLRs are dominantly expressed in cultured human podocytes. Table 2 also

LPS or PAN-induced injury alters TLR profiles in podocytes
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Table 2 Semi-quantitative gene expression 0 to 4+ by visual estimation in human podocyte, human foreskin fibroblast cell line (HFF) and
human monocytic cell line (THP-1) for Toll like receptor (TLR) TLR1
to TLR10, and cofactors MD-1 and MD-2 on reverse transcription
polymerase chain reaction (RT-PCR). Podocytes were also tested with
and without 10 % fetal bovine serum in media
Podocyte
(serum free)

Podocyte
(with serum)

HFF

THP-1

TLR1

2+

3+

2+

3+

TLR2
TLR3
TLR4
TLR5
TLR6
TLR7
TLR8
TLR9
TLR10
MD-1
MD-2

2+
2+
2+
2+
3+
0
0
0
2+
0
3+

2+
2+
3+
3+
3+
0
0
0
2+
0
3+

2+
3+
4+
3+
4+
0
0
0
3+
0
4+

3+
2+
4+
3+
4+
3+
3+
3+
3+
3+
4+

shows that podocytes express cofactor MD-2 (Lymphocyte
antigen 96), but not MD-1 (Lymphocyte antigen 86). MD2
associates with TLR-4 to form homodimers and, with TLR2 to form heterodimers with TLR-1 or TLR-6.
Table 2 presents a comparison of the effect of FBS in the
cell culture medium on TLR expression in podocytes.
Exclusion of FBS in the medium caused only a slight
decrease in the expression of TLR-1, 4 and 5. Thus, changes
observed in the following experiments were free of interference from serum in the cell culture medium.
Table 2 also shows the expression of TLR subtypes in
THP-1 and HFF cells. These cells are routinely used in our
laboratory as reference for comparing TLR gene expression
using a numeric scale (0–4+) (Yew et al. 2010). The THP-1
cell line expresses all of the known 10 human TLRs, MD-1
and MD-2. Overall expression of TLRs in podocytes was
comparable to that observed in the HFF cell line.
Puromycin aminonucleoside (PAN) and lipopolysaccharide
(LPS) deform podocyte morphology and disrupt the actin
cytoskeleton
Both LPS and PAN elicited a similar dose-dependent response
in the podocyte cytoskeleton. LPS (1–50 μg/ml) caused dosedependent changes in the actin cytoskeleton and podocyte
morphology (Fig. 2a). PAN (6 to 90 μg/ml) also caused an
incremental loss of fine F-actin stress fibers in the actin
cytoskeleton as observed by Phalloidin staining (Fig. 2b). At
higher concentrations, both LPS and PAN caused formation of
thick cortical actin network after a 24-h exposure (arrow
heads, Fig. 2a and b). These observations were further

corroborated by crystal violet staining which showed blunting
and/or loss of cytoplasmic processes in podocytes exposed to
PAN for 24 h (Fig. 2b). LPS- or PAN-induced changes in
podocyte morphology and actin cytoskeleton were virtually
indistinguishable by microscopy. Thus, PAN at 60 μg/ml or
LPS at 25 μg/ml appeared to induce changes in the actin
cytoskeleton and podocyte morphology without causing cell
lysis. Subsequent experiments were carried out using PAN or
LPS at these concentrations to determine the effects of these
treatments on TLR expression and cytokine production.
LPS, but not PAN, activates the MyD88-dependent TLR
signaling pathway
Figures 3 and 4 show the relative gene-specific mRNA
expression (RE) for experimental genes of interest normalized
against β-actin, a housekeeping gene that should not be acutely affected. LPS caused time-dependent changes in TLR expression profile at 0, 1 and 6 h. Results presented in Figs. 3
and 4 are annotated in Table 3 for a convenient summary.
Treatment of podocytes with LPS caused more than an
8-fold increase in the gene expression of TLRs-1, 2, 3 and 4
(TLR1>TLR4≥TLR2>TLR3) and a 4 to 6-fold increase in
TLR-6 and 5 within 1 h. After 6 h, the expression of TLRs-2,
3, 4 decreased but that of TLR-1 and TLR-6 continued to
increase. The overall profile of TLRs following stimulation
with LPS was (TLR-1>6>2≥4>3≈5). LPS also caused a
smaller increase in TLR-5 expression at both time points.
Thus, LPS at concentrations commonly used in models of
MCD, stimulated the expression of all transmembrane TLRs
in podocytes by at least 4-fold at both 1 and 6 h. However, it
did not induce the expression of endosomal TLRs 7–9. In
contrast to LPS, PAN did not cause greater than a 4-fold
increase in any of the TLRs at 1 or 6 h. Interestingly, both
LPS and PAN caused a comparable increase in the expression
of TLR-3 and −5. However, while TLR-3 and −5 were among
the most up-regulated TLRs by PAN, these TLRs were among
the least up-regulated by LPS. The expression of TLR-1 was
least affected by PAN, and, in contrast, it was the TLR most
up-regulated by LPS. Thus, PAN induced a small but persistent increase in TLRs 2 and 5, a transient increase in TLR-4
and a gradual increase in TLRs 3 and 6 between 1 and 6 h.
Figure 4 shows the effect of PAN or LPS on the expression of the adaptor molecules involved in TLR signaling at
0, 1 and 6 h. LPS caused up-regulation of MyD88 at 1 h by
more than 12-fold, and these levels were maintained at 6 h.
The corresponding increase in the expression of NF-κB was
approximately 4-fold at both 1 and 6 h (p<0.05 vs. Control).
In keeping with the mild increase in TLR-3 expression, LPS
induced only a minimal increase in the expression of TRIF
and IRF3. In contrast, PAN did not induce a notable change
in the expression of MyD88 or TRIF, suggesting that the
observed small increase in TLRs (Fig. 3) did not generate a
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Fig. 2 Effect of LPS or PAN on actin cytoskeleton and cell morphology.
Control untreated podocytes show fine cytoplasmic F-actin stress fibers
with F-actin phalloidin staining. Podocytes exposed to LPS or PAN show
loss of fine F-actin stress fibers (arrow) and appearance of thick cortical

distribution (arrowheads) at the highest concentration of each agent at the
end of 24 h incubation with LPS or PAN (upper panels, 2A and 2B). The
change in actin cytoskeleton reflected a change in cell morphology by
crystal violet (0.1 %) staining (lower panels, 2A and 2B)

significant downstream signaling response. Thus, LPS primarily activated the MyD88-dependent TLR signaling pathway involving NF-κB in human podocytes while PAN did
not produce a comparable effect.

(p<0.0001), PAN at 1 h 2.6±0.7 (p<0.0001) and PAN at 6 h
4.5±1.6 (p00.003). Interestingly, PAN caused a rapid but less
robust nuclear translocation of NF-κB than LPS (translocation
within 1 h versus 6 h) (Fig. 5a and b).

Nuclear translocation of NF-κB

PAN and LPS differ in their effects on cytokine production

In order to verify that LPS treatment of podocytes leads to
activation of the canonical signaling TLR pathway, we measured the LPS-elicited NF-κB nuclear translocation.
Treatment of podocytes with LPS for 6 h resulted in a significant nuclear translocation of NF-κB (Fig. 5). The maximum
intensity as measured (mean±SD) by confocal microscopy for
the whole cell in control podocytes was 3.4±0.9, LPS at
1 h 2.5±0.7, LPS at 6 h 4.2±0.3, PAN at 1 h 2.3±0.2
and PAN at 6 h 3.9±0.34, with a nuclear/cytoplasmic ratio
of 0.7±0.1, LPS at 1 h 0.7±0.2, LPS at 6 h 1.7±0.5,
PAN at 1 h 1.2±0.3 and PAN at 6 h 1.2±0.4, which
would give a mean NF-κB nuclear activity based on
immunofluorescence intensity for control podocytes as
2.3±0.3, LPS at 1 h 1.6±0.5 (p00.64), LPS at 6 h 6.8±2.2

Table 4 summarizes the effect of PAN and LPS on cytokines
in podocytes. LPS-treated podocytes showed a significant
increase in IL-6, IL-8, and MCP1, but little change was
observed for MIP1α, IP-10 and IFN-β (Table 4). LPS caused
significant increase in IL-6, IL-8 and MCP1 at both 6 h and
24 h (p<0.05). However, TNFα, IFNα and TGFβ1 were not
detectable (ND). Lack of change in IFN-α or IFN-β suggested
that LPS was eliciting the cytokine response in accordance
with its known effects. In contrast, in accordance with the
small changes in the adapter molecules, PAN also did not
cause significant elevation in the secreted cytokines IL-6,
IL-8, MCP1, MIP-1α, IP-10 or IFN-β. Finally, TNF-α,
IFN-α and TGF-β1 were not detectable (ND) in the supernatants of PAN-treated podocytes (Table 4).

LPS or PAN-induced injury alters TLR profiles in podocytes
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Fig. 3 Effect of lipopolysaccharide (LPS) or puromycin (PAN) for 1 h
or 6 h on gene expression of Toll-like Receptors (TLR 1–6). Quantitative RT-PCR analysis results are expressed as mean fold-change in

experimental groups compared to control untreated cells. β-actin was
used as control. Results presented as mean fold-change in gene expression. (n03; *p<0.05 compare to untreated cells)

Discussion

of the immune system in the origin and/or progression of
MCD is suggested by several observations including its
occurrence with malignancy, immunization, infections and
allergies (Lane and Kaskel 2009) and effective control of
proteinuria by immunosuppressive drugs (Saha and Singh

MCD is the most common form of nephrotic syndrome in
children and is associated with ultrastructural changes in
podocytes but its etiology remains unknown. Involvement
Fig. 4 Effect of
lipopolysaccharide (LPS) or
puromycin (PAN) for 1 h and
6 h on mRNA expression of
MyD88 dependent [upper panel] and TRIF dependent TLR
signaling pathways [lower panel]. Quantitative RT-PCR analysis results are expressed as
mean fold-change in experimental groups compared to untreated control group. β-actin
was used as control. (n03;
*p<0.05 compare to
untreated cells)
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Table 3 Results from Figs. 3 and 4 are summarized to highlight the differences between the effects of LPS and PAN on TLRs, MyD88, NF-kB,
IRF and TRIF at 1 and 6 h
A

B

C

D

Time

LPS/Control ≥3-fold

PAN/Control ≥3-fold

LPS/PAN ≥3-fold

LPS/PAN <3-fold

1h

TLR 1>4≥2>3>6>5
MyD88, NF-κB

TLR-4, 5

TLR-1, 2, 3, 4 and 6
MYD88, NF-κB

TLR-5
IRF3, TRIF

6h

TLR 1>6>2≥4>3≈5
MyD88, NF-κB

TLR-3, 5

TLR-1, 2, 4 and 6
MYD88, NF-κB

TLR-5 and 3
IRF3, TRIF

Columns A and B: LPS caused greater upregulation of TLR-1 than of other subtypes at both 1 and 6 h. PAN consistently upregulated TLR-5 at both
time points. LPS upregulated the expression of MyD88 and NF-κB but PAN did not. TLR-5 was least affected by LPS but most affected by PAN at
both time points
Columns C and D: Expression of TLR-5 was comparable in LPS and PAN treated cell at both 1 and 6 h

2006). However, a role of the adaptive immune system
has been difficult to prove since LPS causes proteinuria
with cytoskeletal changes in podocytes and induces

CD80 in T and B cell deficient SCID mice (Reiser et
al. 2004). The innate immune system in epithelia with
barrier function has received increasing attention (Gribar

Fig. 5 Effect of lipopolysaccharide (LPS) or puromycin (PAN) on
NF-κB nuclear translocation. Figure 5a shows separate and merged
images of NF-κB fluorescence in the cytoplasmic and nuclear compartments at 1 and 6 h. Figure 5b shows representative images and numeric
presentation of fluorescence intensity. Confocal microscopy results were

analyzed for the nuclear/cytoplasmic ratio of fluorescence intensity
presented in the bar graph. LPS caused a gradual increase in
nuclear intensity by 6 h. PAN caused a lower but significant increase
in fluorescence within 1 h that did not show further increase by 6 h.
(**, p<0.001)
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Table 4 Cytokines IL-6, IL-8, MCP1, MIP-1α, IP-10, IFN-β, IFN-α, TNF-α and TGF-β1 concentrations in podocyte supernatant media
following treatment with lipopolysaccharide (LPS) or puromycin aminonucleoside (PAN) at 6 h and 24 h on a Luminex platform
Cytokine

Control

PAN treatment
6h

24 h

LPS treatment
6h

24 h

IL-6 (pg/μgDNA)
MCP1 (pg/μgDNA)
IL-8 (pg/μgDNA)
MIP-1α (pg/μgDNA)
IP-10 (pg/μgDNA)
IFN-β (pg/μgDNA)
IFN-α (pg/μgDNA)
TNF-α (pg/μgDNA)
TGF-β1 (pg/μgDNA)

0.66±0.10
4.47±1.03
13.36±3.67
0.033±0.003
0.073±0.028
0.52±0.13
ND
ND
ND

0.94±0.18
1.45±0.12
1.97±0.26
0.027±0.001
0.031±0.012
0.43±0.01
ND
ND
ND

1.03±0.32
3.64±1.29
6.82±3.93
0.043±0.009
0.315±0.291
0.45±0.05
ND
ND
ND

1.46±0.15*
19.54±2.29*
32.01±1.97*
0.037±0.005
0.08±0.002
0.51±0.13
ND
ND
ND

2.55±0.62*
32.87±1.15*‡
59.47±3.06*‡
0.042±0.004
0.061±0.018
0.36±0.02
ND
ND
ND

Values as mean ± SE; ND0Not detected; *, p<0.05 vs. Control; ‡, p<0.05 vs. 6 h

et al. 2008; Anders and Schlöndorff 2007) and may
prove valuable in understanding the etiology of podocyte
injury in MCD (Brown et al. 2007; Banas et al. 2008;
Coers et al. 1994; Van Den Berg et al. 2000).
Sufficient quantities of several agents may increase glomerular protein permeability (McCarthy et al. 1998; Savin
et al. 2008) and derange podocyte structural characteristics
both in vitro and in vivo. These agents include free radicals,
cytokine IL-13 (Yap et al. 1999), complement membrane
attack complex C5b-9 (Couser 2012), immature differentiating cells (Sellier-Leclerc et al. 2007), PAN and LPS
(Pippin et al. 2009). PAN-induced nephrosis (Frenk et al.
1955; Lannigan 1963) and podocyte injury are also known
to be mediated by oxidants (Suzuki et al. 2001; Marshall et al.
2006; Diamond et al. 1986; Shiiki et al. 1998) and inhibition
of the NOTCH signaling pathway (Ding et al. 2011). LPS, a
TLR-4 ligand, causes podocyte injury that results in decreased
cell numbers, dysregulated gene expression and a disrupted
protein-protein network leading to albuminuria (Sun et al.
2009; Pawar et al. 2009). LPS-induced podocyte injury also
involves generation of oxygen radicals and leads to activation
of NF-κB (Greiber et al. 2002). Thus, podocyte injury in
models of MCD may incorporate diverse mechanisms, each
of which finally result in the same phenotype.
Podocyte cytoskeletal derangement serves as a useful
surrogate of cellular injury and a marker of the phenotype.
Both LPS and PAN caused an incremental dose-dependent
loss of fine F-actin stress fibers and appearance of thickbundles of cortical actin filaments in podocytes (Fig. 2). Similar
changes were reported by other investigators using 50 μg/ml
LPS for up to 72 h (Reiser et al. 2004; Marshall et al. 2006;
Gloy et al. 2000; Smoyer and Ransom 2002). We have
observed similar injurious effects of fluid flow shear stress
on mouse podocytes (Srivastava et al. 2010). We used
cytoskeletal changes as preliminary evidence to present
comparable effects of LPS and PAN.

However, the in vivo models of MCD and many in vitro
studies of podocytes employ large quantities of PAN or
LPS. We surmised that barrier epithelia may be less sensitive to microbial products than leukocytes. Constant exposure to filtered toxins and microbial products in the
Bowman’s capsule may require podocytes to possess natural
resistance to such molecules. We did not notice cell lysis at
PAN concentrations under 100 μg/ml for up to 48 h (unpublished observation) and other investigators did not find
DNA fragmentation (Suzuki et al. 2001). PAN is typically
used at 50–100 μg/ml for 24–48 h or at lower concentration
(5 μg/ml) for longer period (7 days) for in vitro study of
podocytes [Gloy et al. 2000; Coers et al. 1994; Smoyer and
Ransom 2002). Likewise, LPS was also used as 50 μg/ml
levels to study its effect on TLR-4 (Reiser et al. 2004; Banas
et al. 2008). In contrast, only nanogram/mL quantities of
LPS are sufficient to stimulate vascular endothelial cells or
leukocytes (Walia et al. 2012). These observations led us to
consider the possibility that the high quantities of LPS
employed for inducing podocyte injury may alter the expression of multiple TLRs within the innate immune system
and that even PAN may alter TLR expression through heretofore unknown mechanism(s).
As a first step, present experiments showed that podocytes constitutively express TLRs 1–6 and 10 but not the
endosomal TLRs 7–9 (Table 2). This profile of TLRs in
cultured human podocytes resembles that reported in human
tissues (Zarember and Godowski 2002; Medzhitov et al.
1997; Nishiya and DeFranco 2004; Matsumoto et al.
2003). These findings are similar to a recent report with
the exception that we did not detect TLR-9. However, when
stimulated with LPS, culture podocytes responded through
an unanticipated and complex change in TLR profile that
has not been described previously. Briefly, LPS induced an
increase in TLRs 1–4 genes expression within 1 h.
However, by 6 h, the expression of TLRs 2–4 had declined
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but that of TLR-1 and TLR-6 continued to increase (Fig. 3,
Table 3). In summary, LPS (25 μg/mL) caused a minimum
of 4-fold increase in TLRs by 6 h with minimum effect on
TLRs 3 and 5. Increased expression TLR-4 by LPS has been
reported in models of podocyte/glomerular injury (Reiser et
al. 2004; Brown et al. 2007; Banas et al. 2008; Shimada et
al. 2012; Tipping 2008; Kistler and Reiser 2010). We, for
the first time, show that LPS-induced change in podocytes
are most noticeable in TLR-1 and not in TLR-4. In contrast,
PAN induced only a small increase in TLR at 1 h and in
TLRs 3, 5 and 6 at 6 h. Of interest, TLRs 3, 5 and 6 were
least affected by LPS (Fig. 3). The observed translocation of
NF-κB (Fig. 5) did not involve upregulation of the downstream signaling elements of TLR pathway. Therefore, it is
either an effect of PAN-induced oxidative stress and/or
involves a mechanism unclear presently. These preliminary
findings will indeed require further validation. Detailed
studies using siRNA to inhibit mRNA for individual TLRs
and antibodies to block respective proteins will be valuable
in identifying and confirming the role of TLRs in mediating
the observed effect of LPS or PAN on NF-κB. Such approach will further elucidate the differences between epithelial cells and other cell typess that respond to very low
concentrations of LPS e.g., immune or endothelial cells.
LPS-induced up-regulation of multiple TLRs is an interesting finding in the light of some recent reports that suggest
interaction among different TLR subtypes. For example,
while TLR-4 functions as a homodimer and, TLR-2 forms
a heterodimer with TLR-1 or TLR-6 (Adeline et al. 2001;
Farhat et al. 2008). Additionally, TLR-1 appears to have an
antagonistic effect on TLR-4 in endothelial cells (Spitzer et
al. 2002). Parallel increase in TLR-1 expression may attenuate the effects of TLR-4 activation that is considered to
mediate podocyte injury caused by LPS (Reiser et al. 2004;
Banas et al. 2008). However, a persistent increase in TLR-1
expression by LPS leads us to speculate that podocyte injury
by LPS involves upregulation of TLR-1 and its endogenous
ligand(s). A specific endogenous ligand for TLR-1 or TLR1/TLR-2 is not known although several molecules including
heat-shock protein, heparin sulfate and fibronectin function
as endogenous ligands for TLRs (Ospelt and Gay 2010).
These findings suggest that LPS-induced changes in podocytes accompany a loss of exclusivity in receptor-ligand
binding and activation of multiple TLRs that may result into
activation of diverse signaling events. Recent reports suggest that activation of TLRs by antigens, cytokines or viral
ligands results in proteinuria and urinary CD80 (B7-1) in
MCD (Shimada et al. 2012; Ishimoto et al. 2011; Shimada et
al. 2011). In contrast, others did not detect LPS-induced
changes in CD80 despite severe glomerular stress and decreased podocyte numbers (Sun et al. 2009). These diverse
and contradicting findings support our view that the established models of podocyte injury involve complex and
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seemingly antagonistic processes. Non-specific effects of high
LPS or PAN levels may induce heretofore unrecognized
cross-talk between signaling pathways. Our experiments
provide a clear indication of changes initiated by the activation
of multiple TLRs that may foretell the complex role of innate
immune system in models of MCD in vitro or in vivo.
LPS induced the upregulation of MyD88-NF-κB expression was accompanied by only small increases in TRIF and
IRF3 expression (Fig. 1 and 4) while PAN did not cause
comparable changes in these adapters. We analyzed the cell
culture medium for proinflammatory induced by MyD88NF-κB pathway and cytokines known to change in MCD
(Woroniecki et al. 2008; Araya et al. 2006; Suranyi et al.
1993; Wasilewska et al. 2011). We found that cytokines
IL-6, IL-8 and MCP1 were increased at both 6 and 24 h
following stimulation with LPS, and these changes reached
statistical significance at 24 h. Conversely, we did not detect
changes in IFN-α or IFN-β, key elements of the TRIF-IRF3
pathway. In addition, we did not detect a change in IP-10
(CXCL-10), TNFα or TGFβ1 in the medium. Although
the effect of TNFα on podocytes and its role in renal
disease has been widely reported but podocytes express
TNFα only under specific conditions (Sanchez-Niño et al.
2010). PAN did not induce pro-inflammatory cytokines
release despite causing an increase in TLR-5 and TLR-3
expression (Table 4) suggesting that these receptor subtypes engage in a heretofore unknown signaling cross-talk.
Thus, LPS-mediates its effects in podocytes by the canonical TLR-MyD88-NF-κB signaling whereas the translocation of NF-κB induced by PAN appears to be the result of
oxidative stress, a known effect of PAN (Suzuki et al.
2001; Marshall et al. 2006; Diamond et al. 1986).
In summary, cultured podocytes express all membranebound TLR subtypes one of which, TLR-3, also localizes to
endosomes. LPS induces upregulation of several TLRs suggesting an apparent loss of its specificity for TLR-4 at
concentrations used in in vitro models of MCD. While
PAN does not induce major changes in TLR expression,
LPS and PAN induce comparable changes in podocytes
through disparate but complementary mechanisms that increase nuclear translocation of NF-κB. These studies suggest
that barrier epithelia may invoke the innate immune system in
a manner distinct from immune cells or endothelial cells and
that, interactions among TLR subtypes may play a role in
mediating podocyte injury in MCD and other renal diseases.
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